Sherri-Ann Maryna Burnett, M.D.
Co-Author
This page shows the publications co-authored by Sherri-Ann Burnett and Joel Finkelstein.
Connection Strength
3.670
-
Gonadal steroids and body composition, strength, and sexual function in men. N Engl J Med. 2013 12 19; 369(25):2457.
Score: 0.561
-
Randomized trial assessing the effects of ergocalciferol administration on circulating FGF23. Clin J Am Soc Nephrol. 2012 Apr; 7(4):624-31.
Score: 0.492
-
Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women. J Bone Miner Res. 2006 Aug; 21(8):1187-96.
Score: 0.336
-
Age-Related Changes in Bone Density, Microarchitecture, and Strength in Postmenopausal Black and White Women: The SWAN Longitudinal HR-pQCT Study. J Bone Miner Res. 2022 01; 37(1):41-51.
Score: 0.242
-
Dose-Response Relationships Between Gonadal Steroids and Bone, Body Composition, and Sexual Function in Aging Men. J Clin Endocrinol Metab. 2020 08 01; 105(8).
Score: 0.222
-
Antimullerian Hormone and Impending Menopause in Late Reproductive Age: The Study of Women's Health Across the Nation. J Clin Endocrinol Metab. 2020 04 01; 105(4).
Score: 0.217
-
Temporal increases in 25-hydroxyvitamin D in midlife women: Longitudinal results from the Study of Women's Health Across the Nation. Clin Endocrinol (Oxf). 2019 07; 91(1):48-57.
Score: 0.203
-
Gonadal steroid-dependent effects on bone turnover and bone mineral density in men. J Clin Invest. 2016 Mar 01; 126(3):1114-25.
Score: 0.163
-
Insulin secretion and sensitivity in healthy adults with low vitamin D are not affected by high-dose ergocalciferol administration: a randomized controlled trial. Am J Clin Nutr. 2015 Aug; 102(2):385-92.
Score: 0.156
-
Serum 25 hydroxyvitamin D, bone mineral density and fracture risk across the menopause. J Clin Endocrinol Metab. 2015 May; 100(5):2046-54.
Score: 0.152
-
Gonadal steroids and body composition, strength, and sexual function in men. N Engl J Med. 2013 Sep 12; 369(11):1011-22.
Score: 0.138
-
Prevalence and predictors of vitamin D deficiency in healthy adults. Endocr Pract. 2012 Nov-Dec; 18(6):914-23.
Score: 0.130
-
Bone and the perimenopause. Obstet Gynecol Clin North Am. 2011 Sep; 38(3):503-17.
Score: 0.120
-
Effects of teriparatide treatment and discontinuation in postmenopausal women and eugonadal men with osteoporosis. J Clin Endocrinol Metab. 2009 Aug; 94(8):2915-21.
Score: 0.102
-
Effects of teriparatide retreatment in osteoporotic men and women. J Clin Endocrinol Metab. 2009 Jul; 94(7):2495-501.
Score: 0.102
-
An unusual case of primary hyperparathyroidism with profoundly elevated parathyroid hormone levels. Endocr Pract. 2008 Oct; 14(7):892-7.
Score: 0.098
-
Effects of teriparatide, alendronate, or both on bone turnover in osteoporotic men. J Clin Endocrinol Metab. 2006 Aug; 91(8):2882-7.
Score: 0.083
-
Changes in Regional Fat Distribution and Anthropometric Measures Across the Menopause Transition. J Clin Endocrinol Metab. 2021 08 18; 106(9):2520-2534.
Score: 0.060
-
Serum Sex Hormones and the Risk of Fracture Across the Menopausal Transition: Study of Women's Health Across the Nation. J Clin Endocrinol Metab. 2019 06 01; 104(6):2412-2418.
Score: 0.051
-
Menstrual Cycle Hormone Changes in Women Traversing Menopause: Study of Women's Health Across the Nation. J Clin Endocrinol Metab. 2017 07 01; 102(7):2218-2229.
Score: 0.045
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.